A multi-center study of therapeutic efficacy and safety of platelet components prepared with pathogen inactivation (INTERCEPT) stored for 6 or 7 days prior to transfusion

Hemotherapy and Hemostasis. Hospital Clinic, Barcelona, Spain; Transfusion Medicine, University Hospital, Uppsala, Sweden; EFS Bretagne, Rennes, France; Tissue and Blood Bank of Catalonia, Barcelona, Spain; Western General Hospital, Edinburgh, United Kingdom; Scottish National Blood Transfusion Service, Edinburgh, United Kingdom; Cerus Corporation, Concord, CA, United States of America

Vox Sanguinis. 2010;99((Suppl S1):):13. Abstract No. 3B-S07-03.
Study details